Cristina Granziera obtained an MD at Padova University Medical School (Padova, Italy) in 2001, a Ph.D. in Neuroscience at Lausanne University (Lausanne, Switzerland) in 2007, and the Swiss Neurology board in 2010. In 2011, she was appointed as a lecturer at the University of Lausanne, where she was promoted to senior lecturer in 2014. In 2015, she joined the Massachusetts General Hospital (MGH) and Harvard Medical School (Boston, MA, USA) as an assistant professor in Radiology and assistant in Biomedical Engineering. Currently, she works as a senior consultant neurologist at the University Hospital of Basel, as a professor in neurology and biomedical engineering at the University of Basel, and as co-CEO of the “Research Center for Neuroscience and Neuroimmunology (RC2NB)” in Basel.

The focus of Dr. Granziera’s research is the investigation of the pathogenesis of neuroinflammatory and cerebrovascular diseases - such as multiple sclerosis, neuroHIV, migraine, and stroke- using state-of-the-art neuroimaging methods. She is particularly interested in the combination of multiple quantitative MRI contrasts to achieve the highest sensitivity and specificity to brain tissue pathology, as well as in multi-modal approaches like MRI-PET. Her goal is to propose new models of disease impact and innovative tools to study disease evolution, by using the combined information of neuroimaging data, biological and clinical markers of disease.